Streetbeat News

Stock Prices

ARDS

BPTS

KPTI

MASI

NMTR

Biophytis S.A. (BPTS) shares surged 53.9% after signing a partnership with SEQENS to produce Sarconeos (BIO101) active compound. Aridis Pharmaceuticals, Inc. (ARDS) shares gained 41.8% after EMA announced positive feedback on the company's proposed Phase 3 study AR-301. Karyopharm Therapeutics Inc. (KPTI) rose 26.1% after receiving FDA Fast Track Designation for Selinexor for Myelofibrosis. 9 Meters Biopharma, Inc. (NMTR) fell 59% and Masimo Corporation (MASI) fell 27.3% after reporting weak preliminary revenue results for Q2.

Portfolio Pulse from Lisa Levin

July 18, 2023 | 12:12 pm

MASI

Masimo Corporation reported weak preliminary Q2 revenue results, leading to a 28% dip in pre-market trading. The company also reduced its revenue guidance for 2023. Following the announcement, Stifel and Needham analysts cut their price targets on Masimo.

Portfolio Pulse from Lisa Levin

July 18, 2023 | 12:12 pm

BAC

Bank of America Corp (NYSE:BAC) reported a 19% YoY increase in Q2 FY23 net income to $7.4 billion, surpassing Street expectations. EPS was $0.88, beating the consensus of $0.84. Revenue rose 11% YoY to $25.33 billion, also beating the consensus. Segment net income varied, with Global Banking seeing a 76% YoY increase. The bank's CET1 ratio was 11.6%, up 110 bps from a year ago. BAC shares are trading higher by 0.51% at $29.55 premarket.

Portfolio Pulse from Anusuya Lahiri

July 18, 2023 | 12:06 pm

PLD

Prologis has revised its FY23 core FFO guidance upwards to $5.56-$5.60 from $5.42-$5.50. The company also increased its EPS guidance to $3.30-$3.40 from the previous $3.10-$3.25.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2023 | 12:05 pm

ACRX

AcelRx Pharmaceuticals has announced a $10M private placement of securities priced at-the-market under Nasdaq rules.

Portfolio Pulse from Bill Haddad

July 18, 2023 | 12:04 pm

KPTI

Over the past 3 months, 4 analysts have published their opinion on Karyopharm Therapeutics (NASDAQ:KPTI) stock. The company has an average price target of $8.75, a decrease of 27.08% from the previous average price target of $12.00. The analysts' ratings are either bullish or somewhat bullish.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 12:01 pm

COHR

Over the past 3 months, 19 analysts have published their opinion on Coherent (NYSE:COHR) stock. The average price target for Coherent is $44.74, representing a 13.33% decrease from the previous average price target of $51.62. The ratings are mixed with 8 bullish, 2 somewhat bullish, 8 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 12:00 pm

TER

Over the past 3 months, 4 analysts have published their opinion on Teradyne (NASDAQ:TER) stock. The company has an average price target of $106.25, a decrease of 0.7% from the previous average price target of $107.00. The ratings include 1 bullish, 2 somewhat bullish, and 1 indifferent.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 12:00 pm

INTU

In the last quarter, Intuit (NASDAQ:INTU) received 12 analyst ratings, all of which were either bullish or somewhat bullish. The company has an average 12-month price target of $513.08, which has increased by 1.78% over the past month.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 12:00 pm

AMZN

GOOG

GOOGL

INFY

META

MSFT

WIT

Infosys Limited's stock is trading higher after disclosing a $2 billion deal with an existing client to provide AI and automation-led services over five years. Wipro Limited plans to invest $1 billion into AI over the next three years. Microsoft's investment in OpenAI has triggered an AI war with companies like Alphabet, Meta Platforms, and Amazon. Infosys reported Q4 FY23 revenue growth of 6.4% to $4.55 billion, missing the consensus of $4.74 billion.

Portfolio Pulse from Anusuya Lahiri

July 18, 2023 | 11:55 am